CRDLCardiol Therapeutics Inc.

Nasdaq cardiolrx.com


$ 2.62 $ -0.05 (-1.69 %)    

Friday, 31-May-2024 15:54:52 EDT
QQQ $ 454.82 $ -0.42 (-0.09 %)
DIA $ 398.57 $ 4.48 (1.17 %)
SPY $ 530.36 $ 1.86 (0.35 %)
TLT $ 91.26 $ 0.01 (0.01 %)
GLD $ 225.37 $ -1.97 (-0.91 %)
$ 2.57
$ 2.66
$ 2.61 x 405
$ 2.62 x 700
$ 2.55 - $ 2.66
$ 0.63 - $ 2.65
761,210
na
167.96M
$ 1.57
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 canaccord-genuity-maintains-buy-on-cardiol-therapeutics-raises-price-target-to-8

Canaccord Genuity analyst Edward Nash maintains Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and raises the price target fr...

 hc-wainwright--co-reiterates-buy-on-cardiol-therapeutics-maintains-9-price-target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and maintains $9 ...

 hc-wainwright--co-initiates-coverage-on-cardiol-therapeutics-with-buy-rating-announces-price-target-of-9

HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Cardiol Therapeutics (NASDAQ:CRDL) with a Buy rating...

 cardiol-therapeutics-q4-eps-009-beats-012-estimate

Cardiol Therapeutics (NASDAQ:CRDL) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of ...

 cbd-to-treat-heart-failure-new-study-shows-its-cardioprotective-effects

On Tuesday, Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) announced positive study results demonstrating that subcutaneo...

 why-murphy-canyon-acquisition-shares-are-trading-higher-by-around-32-here-are-20-stocks-moving-premarket

Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesda...

 cantor-fitzgerald-reiterates-overweight-on-cardiol-therapeutics-maintains-3-price-target

Cantor Fitzgerald analyst Charles Duncan reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Overweight and maintains $3 pr...

 canaccord-genuity-maintains-buy-on-cardiol-therapeutics-raises-price-target-to-6

Canaccord Genuity analyst Edward Nash maintains Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and raises the price target fr...

 reported-earlier-cardiol-therapeutics-says-first-patient-enrolled-in-phase-2-study-of-cardiolrx-for-pericarditis

Cardiol Therapeutics CEO David Elsley shared news the company has hit a major milestone in that the first patient has been enro...

Core News & Articles

Oakville, Ontario--(Newsfile Corp. - November 14, 2022) - Cardiol Therapeutics Inc. (NASDAQ:CRDL) (TSX:CRDL) ("Cardiol"...

 stocks-that-hit-52-week-lows-on-friday

  On Friday morning, 446 companies hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 200 companies hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  During Tuesday's session, 78 companies made new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 838 companies hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-monday

  During Monday's trading, 528 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-friday

  On Friday, 404 stocks made new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION